共 23 条
[11]
Favus,MJ,Christakos,S. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism . 1996
[12]
Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. Silverberg SJ,Gartenberg F,Jacobs TP,et al. The Journal of Clinical Endocrinology . 1995
[13]
Intravenous zoledronic acid in postmenopausal women with low bone density. IR Reid,JP Brown,P Burckhardt,Z Horowitz,P Richardson,U Trechsel,A Widmer,JP Devogelaer,JM Kaufman,P Jaeger,JJ Body,ML Brandi,J Broell,R Micco,AR Genazzani,D Felsenberg,J Happ,MJ Hooper,J Ittner,G Leb,H Mallmin,T Murray,S Ortolani,A Rubinacci,M Saaf,G Sam. The New England Journal of Medicine . 2002
[14]
Skeletal effects of two years of treatment with low physiological doses of recombinant human growth horomone ( GH)in patients with aldult -onset GH deficiency. Janssen Y J,Handy N A,Frolich M,et al. The Journal of Clinical Endocrinology . 1998
[15]
Growth hormone treatment of adults with growth hormone deficiency:results of a 13-month placebo controlled cross-over study. Whitehead HM,Boreham C,McIlrath EM,Sheridan B,Kennedy L,Atkinson AB,Hadden DR. Clinical Endocrinology . 1992
[16]
Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17
[17]
Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17
[18]
Effect of fluoride treatment on the fracturerate in postmenopausal women with osteoporosis. RiggsBL,HodgsonSF,O‘FallonWM,ChaoEY,WahnerHW,MuhsJM,Cedel SL,Melton LJ, 3rd. The New England Journal of Medicine . 1990
[19]
Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Kousteni S,Chen JR,BellidoT,et al. Science . 2002
[20]
Circulating IGF-l: New Perspectives for a New Century. Rosen C J,Pollak M. Trends in Endocrinology and Metabolism . 1999